However, in wild-type mice without CD8+ T cells, treatment with the PSB1115 did not inhibit the growth of the KPC subcutaneous tumors indicating paracrine adenosine signaling through Adora2b on CD8+ T cells reduces their anti-tumor properties in PDAC (4). The gene discussed is CD8A; the disease is neoplasm.